Pošalji zapis e-poštom: Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab vs. Standard Intensive Chemotherapy (hyper-CVAD) as Frontline Therapy for Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: a Propensity Score Analysis